About Careers Internship MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Hemophilia B Treated With Gene Therapy

by Dr. Trupti Shirole on December 11, 2011 at 6:53 PM
Font : A-A+

Hemophilia B Treated With Gene Therapy

British researchers have successfully treated six patients suffering from hemophilia B (blood-clotting disease) by injecting them with the correct form of a defective gene.

Researchers at St. Jude Children's Research Hospital in Memphis, prepared a good version of the human gene for the clotting agent known as Factor IX. Research team led by Dr. Amit C. Nathwani of University College London recruited and treated the patients by infusing the delivery virus into their veins, while researchers at the Children's Hospital of Philadelphia monitored their immune reactions. The corrected version was delivered via the virus to the patient's liver cells. They are the only cells in the body capable of producing certain clotting factors missing or deficient in people with hemophilia.

Advertisement

It was seen that a single injection enabled 4 out of the 6 patients to produce small amounts of clotting factor (Factor IX) on their own which was enough stop the usual treatment, injections of Factor IX concentrate prepared from donated blood. The other 2 patients required to continue with the protein injections, but less frequently. In fact the patients continued to produce their own Factor IX for up to 22 months. The treatment was more efficient as the research team had treated the patients with steroids to suppress immune system attacks on the virus.

With a view to ascertain the highest dose that does not set off an immune system attack, 20 more patients will be treated to assess the best dose of the virus. Scientists hope that if everything goes well, this genetic treatment for hemophilia B could be available for widespread use in a couple of years.

The current treatment costs a patient about $300,000 per year, with a possible lifetime cost of $20 million. But the new gene therapy injection costs just $30,000.

The study is reported in 'The New England Journal of Medicine'.

Source: Medindia
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
Quiz on Low-Calorie Diet for Diabetes
World Heart Day in 2022- Use Heart for Every Heart
Anemia among Indian Women and Children Remains a Cause of Concern- National Family Health Survey-5
View all
Recommended Reading
News Archive
Date
Category
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
DNA Finger Printing Genetic Counseling Reiki and Pranic Healing Pancreas von Willebrand Disease Bleeding Disorders Hemophilia 

Most Popular on Medindia

Vent Forte (Theophylline) Post-Nasal Drip Drug Interaction Checker Sanatogen Noscaphene (Noscapine) Blood Donation - Recipients Drug - Food Interactions Selfie Addiction Calculator Drug Side Effects Calculator Turmeric Powder - Health Benefits, Uses & Side Effects
This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use
open close
CONSULT ONLINE WITH A DOCTOR

×

Hemophilia B Treated With Gene Therapy Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests